Login
Home / 9989.HK : HKSE
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

HKD 4.16 -$1.00 (-19.48%)
HKSE · 15 Sep 2026 08:08 UTC
Previous Close
HKD 4.2
Day Range
HKD 4.02HKD 4.23
Year Range
HKD 3.74HKD 5.96
Market Cap
14.03B
AVG Volume
529.28K
Trailing/Forward PE
67.19/9.23
PEG ratio
11.29
Dividend Yield
1.55%
Next Earnings Date
2026-11-04
Primary Exchange
Hong Kong Stock ExchangeHK
Revenue (CNY)
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (CNY)
-400M-200M0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (CNY)
-250M0250M500M750M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (CNY)
-250M0250M500M750M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (CNY)
-250M0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (CNY)
-0.200.20.424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (CNY)
-200M0200M400M600MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (CNY)
01B2B3B4BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-20-15-10-50524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%10%20%30%40%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
-2%0%2%4%6%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (CNY)
00.10.20.3May 21Jun 22May 23May 25May 26
Book Value Per Share (CNY)
02.557.51024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (CNY)
05B10B15B20B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
510152025med 15.28Dec 23Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
10%15%20%25%30%35%med 25.46%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
0.811.21.41.61.8med 1.17Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EV/EBITDA
050100150med 10.91Mar 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
2345med 3.47Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Book
0.40.50.60.70.8med 0.52Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
9989.HK
Stockpicker

Video analysis: 9989.HK

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.